| scholarly article | Q13442814 |
| P50 | author | John H. L. Playfair | Q29643444 |
| P2093 | author name string | Taverne J | |
| Depledge P | |||
| P2860 | cites work | An endotoxin-induced serum factor that causes necrosis of tumors | Q24564406 |
| Possible importance of macrophage-derived mediators in acute malaria | Q24603093 | ||
| Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells | Q33902137 | ||
| Splenomegaly, enhanced phagocytosis, and anemia are thymus-dependent responses to malaria | Q34447667 | ||
| Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties | Q36042443 | ||
| Endotoxin-induced serum factor kills malarial parasites in vitro. | Q36423783 | ||
| Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation | Q36424365 | ||
| Induction and immunological properties of tumor necrosis factor | Q39744802 | ||
| Protection of mice againstBabesiaspp. andplasmodiumspp. with killedCorynebacterium parvum | Q40752611 | ||
| The immunological response of CBA mice to P. yoelii. I. General characteristics, the effects of T-cell deprivation and reconstitution with thymus grafts | Q40788628 | ||
| Plasmodium yoelii and Plasmodium vinckei: the effects of nonspecific immunostimulation on murine malaria | Q40797652 | ||
| Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei | Q40828833 | ||
| Antibody responses in mice protected against malaria by vaccination | Q41200486 | ||
| Spleen-derived mononuclear cell chemotactic factor in malaria infections: a possible mechanism for splenic macrophage accumulation | Q41230007 | ||
| Measurement of the growth rate of the erythrocytic stages ofPlasmodium bergheiand comparisons of the potency of inocula after various treatments | Q41939994 | ||
| Increased nonspecific resstance to malaria produced by administration of killed Corynebacterium parvum | Q44164016 | ||
| Protection of mice against Babesia and Plasmodium with BCG | Q45068799 | ||
| T-cell activation in murine malaria | Q47846120 | ||
| Effect of bacterial endotoxin on the course of Plasmodium berghei infection | Q47961203 | ||
| The induction of tyrosine aminotransferase activity and its use as an indirect assay for endotoxin in mice infected with Plasmodium vinckei petteri | Q47972480 | ||
| Two distinct types of non-specific immunosuppression in murine malaria | Q47991003 | ||
| Plasmodium berghei: effect of carrageenan on the course of infection of the A/J mouse | Q47991753 | ||
| Lymphocyte traffic and lymphocyte destruction in murine malaria. | Q47992883 | ||
| Purification and physico-chemical characterization of rabbit tumor necrosis factor. | Q54547513 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endotoxins | Q319997 |
| malaria | Q12156 | ||
| P304 | page(s) | 927-934 | |
| P577 | publication date | 1982-09-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor | |
| P478 | volume | 37 |
| Q36982286 | A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. |
| Q36349409 | Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages |
| Q47985635 | Blood-stage malaria in Biozzi high and low antibody responder mice: the importance of antibody and macrophages in immunity |
| Q43687440 | Changes in the capacity of macrophages and T cells to produce interleukins during marine malaria infection |
| Q24300078 | Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor |
| Q58845289 | Effect of recombinant tumour necrosis factor on acute infection in mice with Toxoplasma gondii or Trypanosoma cruzi |
| Q44278920 | Factors contributing to the development of cerebral malaria. II. Endotoxin. |
| Q47927875 | Immunity to an attenuated variant of Plasmodium berghei: role of some non-specific factors |
| Q36984332 | Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon |
| Q47930512 | Interactions between Trypanosoma brucei and Babesia spp. and Plasmodium spp. in mice |
| Q40162901 | Killing of Plasmodium falciparum by eosinophil secretory products. |
| Q37098283 | Killing of Plasmodium yoelii by enzyme-induced products of the oxidative burst |
| Q40599856 | Killing of blood-stage murine malaria parasites by hydrogen peroxide. |
| Q40181908 | Killing of human malaria parasites by macrophage secretory products. |
| Q47921040 | Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination |
| Q58853127 | Macrophage functions in Biozzi mice |
| Q47975735 | Macrophages from Babesia and malaria infected mice are primed for monokine release |
| Q40196682 | Malaria: immunity, vaccination and immunodiagnosis |
| Q70584353 | Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum |
| Q47911455 | Malarial parasites induce TNF production by macrophages |
| Q37580750 | Necrosin: purification and properties of a cytotoxin derived from a murine macrophage-like cell line |
| Q35838590 | Pathogenesis of malaria and clinically similar conditions |
| Q40096535 | Perspectives for malaria vaccination |
| Q47900144 | Raised serum levels of tumour necrosis factor in parasitic infections |
| Q44279256 | Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. |
| Q41029519 | Regulation of infectivity of Plasmodium to the mosquito vector |
| Q47892787 | Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo |
| Q47976521 | T-independent macrophage changes in murine malaria |
| Q44461540 | The importance of parasite load in the killing of Plasmodium vinckei in mice treated with Corynebacterium parvum or alloxan monohydrate |
| Q35095122 | Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection |
| Q37021301 | Tumor necrosis factor does not induce Plasmodium falciparum crisis forms |
| Q35590901 | Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae |
| Q36976057 | Tumor necrosis factor production by human macrophages stimulated in vitro by Plasmodium falciparum |
Search more.